logo

For the Inventor, By the Inventor

Gainesville, FL, United States of America

William Reade Kem

This inventor holds 13 USPTO granted patents and 1 published patent application and 2 EPO patents. Top assignees: University of Florida Research Foundation Inc., Duke University, Bachem Bioscience, Ing.. Active years: 1996-2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: William Reade Kem. Retrieved from https://idiyas.com/inventor/william-reade-kem

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 13 

% Patents Active = 61.5

 

Average Co-Inventor Count = 3.4

ph-index = 5

Forward Citations = 272(Granted Patents)


Location History:

  • Gainsville, FL (US) (1998)
  • Gainesville, FL (US) (1996 - 2016)

Company Filing History:

goldMedal13 out of 3,050 
 
University of Florida Research Foundation Inc.
 patents
silverMedal2 out of 2,078 
 
Duke University
 patents
bronzeMedal1 out of 1 
 
Bachem Bioscience, Ing.
 patent
4. 1 out of 5 
 
Biomolecular Research Institute Ltd.
 patents
5. 1 out of 320 
 
Taiho Pharmaceutical Company Limited
 patents
6. 1 out of 16,008 
 
University of California
 patents
7. 1 out of 2,655 
 
University of Pennsylvania
 patents
where one patent can have more than one assignee

Years Active: 1996-2016

Loading Chart...
Loading Chart...
13 patents (USPTO):Explore Patents
1. 9440948 - Nicotine compounds and analogs thereof, synthetic methods of making compounds, and methods of use (2016-09-13),
2. 9233109 - Compositions, methods of use, and methods of treatment (2016-01-12),
3. 9150558 - Nicotine receptor targeted compounds and compositions (2015-10-06),
4. 8592458 - Alpha7 nicotinic receptor selective ligands (2013-11-26),
5. 8093269 - Alpha 7 nicotinic receptor selective ligands (2012-01-10),
6. 7307171 - Materials and methods for inhibiting fouling of surfaces exposed to aquatic environments (2007-12-11),
7. 7087106 - Materials and methods for inhibiting fouling of surfaces exposed to aquatic environments (2006-08-08),
8. 6630491 - Use of nicotinic analogs for treatment of degenerative diseases of the nervous system (2003-10-07),
9. 6077680 - ShK toxin compositions and methods of use (2000-06-20),
10. 5977144 - Methods of use and compositions for benzylidene- and (1999-11-02),
11. 5741802 - Anabaseine derivatives useful in the treatment of degenerative diseases (1998-04-21),
12. 5734059 - Production intermediate and process for producing pyridine derivative (1998-03-31),
13. 5516785 - Use of nicotinic analogs for treatment of degenerative diseases of the (1996-05-14),

Title: The Innovations of William Reade Kem

Introduction

William Reade Kem is a notable inventor based in Gainesville, Florida, recognized for his significant contributions to the field of nicotine compounds and their applications. With a total of 13 patents to his name, Kem has made strides in developing synthetic methods and treatments related to nicotine dependence and neuropsychiatric disorders.

Latest Patents

Kem's latest patents focus on nicotine compounds and analogs, including synthetic methods for creating these compounds. His work encompasses various embodiments that provide for compounds such as 2'substituted nicotine compounds, azetidine compounds, and ether-linked nicotine compounds. Additionally, he has developed methods for synthesizing these compounds and treating conditions using them. His patents also detail methods for selectively stimulating alpha7 nAChR and alpha4beta2 receptors, which are crucial in the treatment of nicotine dependence and related disorders.

Career Highlights

Throughout his career, Kem has been associated with prestigious institutions such as the University of Florida Research Foundation and Duke University. His work has not only advanced the scientific understanding of nicotine but has also contributed to the development of therapeutic methods for individuals struggling with nicotine addiction and associated mental health issues.

Collaborations

Kem has collaborated with notable colleagues, including Ferenc Soti and Edwin M Meyer, enhancing the impact of his research through shared expertise and innovative ideas.

Conclusion

William Reade Kem's contributions to the field of nicotine research and treatment exemplify the importance of innovation in addressing public health challenges. His patents and collaborations continue to influence the development of effective therapies for nicotine dependence and related disorders.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…